- Research works
- 0 fractional, all time
- Citations
- 6 35.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: OrphageniX (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does OrphageniX (United States) publish most on?
By volume: Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research and Retinoids in leukemia and cellular processes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 2 Acute Myeloid Leukemia Research Hematology 0 works
- 3 Retinoids in leukemia and cellular processes Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
Other research institutions in Wilmington
- DuPont (United States)
- AstraZeneca (United States)
- Christiana Care Health System
- Alfred I. duPont Hospital for Children
- Winterthur Museum Garden and Library
- Incyte (United States)
- Office of the Governor
- InterDigital (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.